Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission

European Journal of Pharmacology

Volumn 312, Issue 1, 1996, Pages 7-14

  Keil II, Gary J ^a,b   DeLander, Gary E ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

(Mouse); Adenosine, pharmacology; Allodynia; Antinociception; Spinal cord

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 5' AMINO 5' DEOXYADENOSINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; KAINIC ACID; METHYLXANTHINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID; PENTOSTATIN; SUBSTANCE P; THEOPHYLLINE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY STIMULATION; SENSORY SYSTEM; SPINAL CORD;

EID: 0030593746     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00444-X     Document Type: Article

References (51)

1. Aanonsen, L.M. and G.L. Wilcox, 1987, Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists, J. Pharmacol. Exp. Ther. 243, 9.
2. Ballarín, M, B.B. Fredholm, S. Ambrosio and N. Mahy, 1991, Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism, Acta Physiol. Scand. 142, 97.
3. Belfrage, M., A. Sollevi, M. Segerdahl, K-F. Sjölund and P. Hansson, 1995, Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain, Anesth. Analg. 81, 713.
4. Braas, K.M., A.C. Newby, V.S. Wilson and S.H. Snyder, 1986, Adenosine-containing neurons in the brain localized by immunocytochemistry, J. Neurosci. 6, 1952.
5. 3H]NECA in rat striatal membranes, Mol. Pharmacol. 29, 331.
6. Cerne, R., M. Jiang and M. Randic, 1992, Cyclic adenosine 3′5′-monophosphate potentiates excitatory amino acid and synaptic responses of rat spinal dorsal horn neurons. Brain Res. 596, 111.
7. 2 adenosine receptors in the rat spinal cord, J. Pharmacol. Exp. Ther. 242, 905.
8. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study, J. Pharmacol. Exp. Ther. 247, 757.
9. Davies, L.P., J. Baird-Lambert and D.D. Jamieson, 1982, Potentiation of pharmacological responses to adenosine, in vitro and in vivo, Gen. Pharmacol. 13, 27.
10. DeLander, G.E. and G.J. Hopkins, 1986, Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine, J. Pharmacol. Exp. Ther. 239, 88.
11. 2 adenosine receptors in spinal mechanisms of antinociception, Eur. J. Pharmacol 139, 215.
12. DeLander, G.E. and J.J. Wahl, 1988, Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally, J. Pharmacol. Exp. Ther. 246, 565.
13. DeLander, G.E. and J.J. Wahl, 1989, Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters, J. Pharmacol. Exp. Ther. 251, 1090.
14. DeLander, G.E. and J.J. Wahl, 1991, Descending systems activated by morphine (i.c.v.) inhibit kainic acid (i.t.)-induced behavior, Pharmacol. Biochem. Behav. 39, 155.
15. 3H]nitrobenzylthioinosine binding sites in rat spinal cord and primary afferent neurons, Brain Res. 347, 321.
16. Geiger, J.D. and J.I. Nagy, 1986, Distribution of adenosine deaminase activity in rat brain and spinal cord, J. Neurosci. 6, 2707.
17. Geiger, J.D., F.S. LaBella and J.I. Nagy, 1984, Characterization and localization of adenosine receptors in rat spinal cord, J. Neurosci. 4, 2303.
18. Holmgren, J. Hedner, T. Mellstrand, G. Nordbert and T. Hedner, 1986, Characterization of the antinociceptive effects of some adenosine analogues in the rat, Arch. Pharmacol. 334, 290.
19. Hylden, J.L.K. and G.L. Wilcox, 1980, Intrathecal morphine in mice, A new technique, Eur. J. Pharmacol. 67, 313.
20. Jurna, I., 1984, Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord, Arch. Pharmacol. 327, 23.
21. Keil, II, G.J. and G.E. DeLander, 1992, Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor, Life Sci. 51, PL51.
22. Keil, II, G.J. and G.E. DeLander, 1994, Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine-and opioid agonist-induced antinociception in mice, Eur. J. Pharmacol. 271, 37.
23. Keil, II, G.J. and G.E. DeLander, 1995, Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors, J. Pharmacol. Exp. Ther. 274, 1387.
24. Li, J. and E. Perl, 1994, Adenosine inhibition of synaptic transmission in the substantia gelatinosa, J. Neurophysiol. 72, 1611.
25. Malmberg, A.B. and T.L. Yaksh, 1993, Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50, 488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction, Anesthesiology 79, 270.
26. 2α-induced allodynia in conscious mice, Pain Res. 7, 129.
27. Nagaoka, H., S. Sakurada, T. Sakurada, S. Takeda, Y. Nakagawa, K. Kisara and Y. Arai, 1993, Theophylline-induced nociceptive behavioral response in mice: Possible indirect interaction with spinal N-methyl-D-aspartate receptors, Neurochem. Int. 22, 69.
28. Nehlig, A., J.-L., Daval and G. Derby, 1992, Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev. 17, 139.
29. Paalzow, G.H.M., 1994, Noradrenline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophyliine in awake rats, Eur. J. Pharmacol. 252, 87.
30. Paalzow, G.H.M. and L. Paalzow, 1973, The effects of caffeine and theophyliine on nociceptive stimulation in the rat, Acta Pharmacol. Toxicol. 32, 22.
31. Phillis, J.W. and J.P. Edstrom, 1976, Effects of adenosine analogs on rat cerebral cortical neurons, Life Sci. 19, 1041.
32. Poon, A. and J. Sawynok, 1995, Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration, Eur. J. Pharmacol. 286, 177.
33. Post, C., 1984, Antinociceptive effects in mice after intrathecal injection of 5′-N-ethylcarboxamide adenosine, Neurosci. Lett. 51, 325.
34. Radulovacki, R., R.M. Virus, M. Djuricic-Nedelson and R.D. Green, 1983, Hypnotic effects of deoxycoformycin in rats, Brain Res. 271, 392.
35. Reeve, A.J. and A.H. Dickenson, 1995a, The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurons in the anesthetized rat, Br. J. Pharmacol. 116, 2221.
36. Reeve, A.J. and A.H. Dickenson, 1995b, Electrophysiological study on spinal antinociceptive interactions between adenosine and morphine in the dorsal horn of the rat, Neurosci. Lett. 194, 81.
37. Salter, M.W., Y. DeKoninck and J.L. Henry, 1993, Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn, Prog. Neurobiol. 42, 125.
38. Santicioli, P. E. Del Bianco, M. Tramontana and C.A. Maggi, 1992, Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide-and substance P-like immunoreactivities from primary afferents in rat spinal cord, Neurosci. Lett. 144, 211.
39. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord, Eur. J. Pharmacol. 231, 139.
40. Sawynok, J. and M.I. Sweeney, 1989, The role of purines in nociception, Neuroscience 32, 557.
41. Sawynok, J. and T.L. Yaksh. 1993, Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action, Pharmacol. Rev. 45, 43.
42. Sawynok, J., M.I. Sweeney and T.D. White, 1986, Classification of adenosine receptors mediating antinociception in the rat spinal cord, Br. J. Pharmacol. 88, 923.
43. Segerdahl, M., A. Ekblom, K.-F. Sjölund, M. Belfrage, C. Forsberg and A. Sollevi, 1995, Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans, NeuroReport 6, 753.
44. Sollevi, A., M. Belfrage. T. Lundeberg, M. Segerdahl and P. Hansson, 1995, Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain, Pain 61, 155.
45. 2 adenosine receptors mediating the purine antinociception, motor, and autonomie function in the rat spinal cord, J. Pharmacol. Exp. Ther. 250, 915.
46. Stone, T.W., 1991, Receptors for adenosine and adenine nucleotides, Gen. Pharmacol. 22, 25.
47. Urban, L., S.W.N. Thompson and A. Dray, 1994, Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters, Trends Neurosci. 17, 432.
48. Vasko, M.R. and H. Ono, 1990, Adenosine analogs do not inhibit potassium-stimulated release of substance P from rat spinal cord slices, Naunyn-Schmied. Arch. Pharmacol. 342, 441.
49. Yaksh, T.L. and G.J. Harty, 1988, Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine, J. Pharmacol. Exp. Ther. 244, 501.
50. Yamamoto, T. and T.L. Yaksh, 1991, Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction, Life Sci. 49, 1955.
51. Zhang, G., P.H. Franklin and T.F. Murray, 1993, Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility, J. Pharmacol. Exp. Ther. 264, 1415.